This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Roly Foulkes, PhD
Chief Scientific Officer at Revolo Biotherapeutics

Profile

As a true drug discoverer, Dr. Roly Foulkes has 25 years of experience building and delivering innovative therapeutic portfolios within the immunology and inflammatory disease space. Roly was at Celltech and UCB for 25 years where he was VP Immunology Research. Since 2012, he worked as an independent consultant with a strong track record advising small and medium sized immunology biopharma companies in developing competitive therapeutic strategies and bringing new innovative molecules to the clinic. Roly has been the CSO for Revolo Biotherapeutics since 2018

Agenda Sessions

  • Resetting the Immune System without Shutting it Down

    14:00